glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa GLP-1 receptor agonists for HS - GLP-1 Dermatology GLP-1 receptor agonists for HS Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis Suppurativa: A Promising New Avenue

GLP-1 Dermatology Hidradenitis suppurativa (HS), a chronic inflammatory skin condition, presents a significant challenge for patients and clinicians alike. Characterized by recurrent, painful nodules, abscesses, and sinus tracts, HS often leads to disfigurement and a substantial reduction in quality of lifeJDD Buzz Series | GLP-1 Agonists for Hidradenitis .... While existing treatments aim to manage symptoms, the search for more effective therapies continues. Emerging research is highlighting the potential of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as a promising new therapeutic avenue for hidradenitis suppurativaIncoporating theGLP-1agents into HS management is very helpful and has been recognized and used with regularity by some of our dermatology ....

Initially developed for type 2 diabetes and obesity management, GLP-1 RAs work by mimicking the action of the naturally occurring hormone GLP-1. This hormone plays a crucial role in regulating blood glucose levels, slowing gastric emptying, and promoting satiety.2天前—GLP-1RAs offer promise for obese HS patients, who are often treatment-resistant, and potentially even for non-obese patients through ... However, recent studies suggest that these agents may offer additional benefits beyond metabolic control, particularly in inflammatory conditions like hidradenitis suppurativa.

One of the key mechanisms through which GLP-1 RAs are thought to benefit patients with hidradenitis suppurativa is through their immunomodulatory and anti-inflammatory properties.The Therapeutic Potential of GLP-1 Receptor Agonists in ... Dr. L Gouvrion and colleagues have explored these effects, suggesting that GLP-1 RAs could offer promise not only for patients with co-existing obesity but also potentially for those without obesity through these immunological pathways.Glucagon-Like Peptide-1 Receptor Agonists Reduce ... The connection between glucagon, like peptide, and 1 receptor agonists is fundamental to understanding their biological action.

For patients with HS and obesity, who are often found to be treatment-resistant, GLP-1 RAs present a compelling option. Studies indicate that GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa primarily through weight loss, which is a common comorbidity and exacerbating factor in HS. However, the benefits may extend beyond weight management2025年12月23日—The biologic plausibility ofGLP-1 receptor agonists for HSlies in their immunomodulatory and anti-inflammatory properties. Preclinical and .... Research is increasingly showing that GLP-1RAs offer promise for obese HS patients, and intriguingly, the potential for therapeutic benefits in managing hidradenitis suppurativa has been observed even in non-obese individuals. This suggests a direct anti-inflammatory effect independent of weight reduction.

The evidence is accumulating.作者：L Gouvrion·被引用次数：5—This cohort study investigates the potential therapeutic benefits ofglucagon-like peptide-1 receptor agonistsin patients withhidradenitis... A systematic review by A Sánchez-Feliciano and colleagues examined the role of glucagon-like peptide-1 receptor agonists in the adjunctive treatment of patients with hidradenitis Suppurativa. Findings from various cohort studies and systematic reviews, including those cited by PK Krajewski, indicate that GLP1-RAs may also offer therapeutic benefits in managing hidradenitis suppurativa. These benefits are not merely anecdotal; clinical observations have shown that GLP-1 RAs such as liraglutide have been associated with decreased HS severity.GLP-1RAs in hidradenitis suppurativa: A systematic review Furthermore, these agents have demonstrated improvements in Hurley stage, a common classification system for HS severity, even when the improvements are independent of weight作者：L Gouvrion·被引用次数：5—This cohort study investigates the potential therapeutic benefits ofglucagon-like peptide-1 receptor agonistsin patients withhidradenitis.... This independent effect underscores the direct impact of GLP-1 receptor agonists for HSGlucagon-like Peptide-1 Receptor Agonists in the ....

The implications of these findings are significant. A study highlighted that glucagon-like peptide-1 receptor agonists reduce surgeries and hospitalizations in hidradenitis suppurativa, pointing towards a tangible reduction in disease burden and healthcare utilization.JDD Buzz Series | GLP-1 Agonists for Hidradenitis ... This suggests that incorporating GLP-1 agents into HS management is very helpful and is already being recognized and utilized by some dermatology professionals.Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis ... The biologic plausibility of GLP-1 receptor agonists for HS lies in their multifaceted actions, including their ability to modulate immune responses and reduce inflammation.

While further large-scale, randomized controlled trials are needed to fully elucidate the long-term efficacy and safety profiles of GLP-1 RAs in the context of hidradenitis suppurativa, the current evidence is highly encouraging. The potential for these medications to improve the lives of individuals suffering from this debilitating condition, offering hope for reduced symptom severity, fewer flares, and a better overall prognosis, marks a significant advancement in dermatological treatment. The ongoing exploration into GLP and 1 pathways continues to unlock new therapeutic potentials for complex inflammatory diseases2025年12月23日—The biologic plausibility ofGLP-1 receptor agonists for HSlies in their immunomodulatory and anti-inflammatory properties. Preclinical and ....